selected publications
- Immunotherapy Plus Surgery Improves Survival in Microsatellite Instability-High Colon Cancer with Isolated Peritoneal Metastases. Cancers. 2025 Academic Article GET IT
- Emerging innovations in theranostics for pancreatic neuroendocrine tumors. NPJ precision oncology. 2025 Review GET IT
- ASO Author Reflections: Risk Stratification Using Genomic Data for Early-Stage Colon Cancer. Annals of surgical oncology. 2025 Academic Article GET IT
-
Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.
Annals of surgical oncology.
2025
Academic Article
GET IT
Times cited: 1 -
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.
Cancer cell.
2024
Academic Article
GET IT
Times cited: 33 -
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
Oncogene.
2023
Academic Article
GET IT
Times cited: 33 - Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non-Muscle-Invasive Bladder Cancer. JCO clinical cancer informatics. 2023 Academic Article GET IT
- Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies. 2023 GET IT
-
Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.
Frontiers in immunology.
2023
Academic Article
GET IT
Times cited: 4 -
Papillary Dermal Elastolysis Secondary to Combination Nivolumab and Cabiralizumab Therapy: Histiocytes and Dermal Mucin as Clues to the Diagnosis.
2021
GET IT
Times cited: 1 -
Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy.
Cell reports.
2021
Academic Article
GET IT
Times cited: 63 -
The Achilles' Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials.
Journal of pancreatology.
2020
Academic Article
GET IT
Times cited: 6 -
Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.
Cancer immunology research.
2017
Academic Article
GET IT
Times cited: 145 -
Patient-derived tumor xenografts: transforming clinical samples into mouse models.
Cancer research.
2013
Review
GET IT
Times cited: 574 -
Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).
Oncotarget.
2011
Academic Article
GET IT
Times cited: 16 -
Second-generation shRNA libraries covering the mouse and human genomes.
Nature genetics.
2005
Academic Article
GET IT
Times cited: 512 -
Synthetic shRNAs as potent RNAi triggers.
Nature biotechnology.
2004
Letter
GET IT
Times cited: 358